BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10618415)

  • 1. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy.
    Kunisada K; Negoro S; Tone E; Funamoto M; Osugi T; Yamada S; Okabe M; Kishimoto T; Yamauchi-Takihara K
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):315-9. PubMed ID: 10618415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes.
    Kunisada K; Tone E; Fujio Y; Matsui H; Yamauchi-Takihara K; Kishimoto T
    Circulation; 1998 Jul; 98(4):346-52. PubMed ID: 9711940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
    Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
    Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein.
    Wang L; Zhang TP; Zhang Y; Bi HL; Guan XM; Wang HX; Wang X; Du J; Xia YL; Li HH
    Sci Rep; 2016 Jun; 6():28399. PubMed ID: 27323684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age.
    Jacoby JJ; Kalinowski A; Liu MG; Zhang SS; Gao Q; Chai GX; Ji L; Iwamoto Y; Li E; Schneider M; Russell KS; Fu XY
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12929-34. PubMed ID: 14566054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor.
    Zhang X; Azhar G; Chai J; Sheridan P; Nagano K; Brown T; Yang J; Khrapko K; Borras AM; Lawitts J; Misra RP; Wei JY
    Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1782-92. PubMed ID: 11247792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice.
    Kanagasabai R; Karthikeyan K; Zweier JL; Ilangovan G
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H963-H975. PubMed ID: 34477462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
    Nelson TJ; Balza R; Xiao Q; Misra RP
    J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes.
    Rong J; Li L; Jing L; Fang H; Peng S
    Int J Toxicol; 2016 May; 35(3):317-26. PubMed ID: 26526549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes.
    Takahashi N; Saito Y; Kuwahara K; Harada M; Tanimoto K; Nakagawa Y; Kawakami R; Nakanishi M; Yasuno S; Usami S; Yoshimura A; Nakao K
    J Mol Cell Cardiol; 2005 Jan; 38(1):185-92. PubMed ID: 15623435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice.
    Zhang Y; Kang YM; Tian C; Zeng Y; Jia LX; Ma X; Du J; Li HH
    PLoS One; 2011; 6(6):e21104. PubMed ID: 21738612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity.
    Wu J; Guo W; Lin SZ; Wang ZJ; Kan JT; Chen SY; Zhu YZ
    Cell Death Dis; 2016 Aug; 7(8):e2339. PubMed ID: 27537522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
    Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
    PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
    van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
    Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gp130 plays a critical role in pressure overload-induced cardiac hypertrophy.
    Uozumi H; Hiroi Y; Zou Y; Takimoto E; Toko H; Niu P; Shimoyama M; Yazaki Y; Nagai R; Komuro I
    J Biol Chem; 2001 Jun; 276(25):23115-9. PubMed ID: 11262406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between ERK1/2 and STAT3 in the modulation of cardiomyocyte hypertrophy induced by cardiotrophin-1.
    Li YJ; Cui W; Tian ZJ; Hao YM; Du J; Liu F; Zhang H; Zu XG; Liu SY; Xie RQ; Yang XH; Wu YZ; Chen L; An W
    Chin Med J (Engl); 2004 Aug; 117(8):1135-42. PubMed ID: 15361284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent effects of doxorubicin on cardiac gene expression.
    Boucek RJ; Miracle A; Anderson M; Engelman R; Atkinson J; Dodd DA
    J Mol Cell Cardiol; 1999 Aug; 31(8):1435-46. PubMed ID: 10423342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ral GDP dissociation stimulator and Ral GTPase are involved in myocardial hypertrophy.
    Kawai M; Kawashima S; Sakoda T; Toh R; Kikuchi A; Yamauchi-Takihara K; Kunisada K; Yokoyama M
    Hypertension; 2003 Apr; 41(4):956-62. PubMed ID: 12642511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
    Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
    J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.